Kevin Fischbeck
Stock Analyst at B of A Securities
(4.04)
# 490
Out of 4,784 analysts
162
Total ratings
64.96%
Success rate
5.45%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $30.12 | +47.74% | 6 | Feb 28, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $380 → $370 | $342.16 | +8.14% | 9 | Jan 27, 2025 | |
| HUM Humana | Upgrades: Neutral | $247 → $308 | $264.58 | +16.41% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $13.20 | +43.94% | 2 | Nov 6, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $675 → $650 | $516.04 | +25.96% | 21 | Oct 16, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $23.57 | +103.65% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $4.49 | -33.18% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $150.22 | -3.47% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $432.00 | +22.69% | 3 | Jul 18, 2024 | |
| MOH Molina Healthcare | Downgrades: Underperform | $439 | $322.85 | +35.98% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $10.64 | -38.91% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $18.30 | -60.38% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $60.04 | +19.92% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $325.04 | +7.68% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $186.18 | -1.71% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $23.95 | +87.89% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $100.78 | -26.57% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.70 | +103.70% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.80 | +108.33% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.59 | +178.55% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 → $50 | $133.14 | -62.45% | 4 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $15.00 | -50.00% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $34.73 | -48.17% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.16 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $35.02 | -45.75% | 2 | Feb 9, 2018 |
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $30.12
Upside: +47.74%
HCA Healthcare
Jan 27, 2025
Maintains: Buy
Price Target: $380 → $370
Current: $342.16
Upside: +8.14%
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $264.58
Upside: +16.41%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $13.20
Upside: +43.94%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $675 → $650
Current: $516.04
Upside: +25.96%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $23.57
Upside: +103.65%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $4.49
Upside: -33.18%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $150.22
Upside: -3.47%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $432.00
Upside: +22.69%
Molina Healthcare
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $322.85
Upside: +35.98%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.64
Upside: -38.91%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $18.30
Upside: -60.38%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $60.04
Upside: +19.92%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $325.04
Upside: +7.68%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $186.18
Upside: -1.71%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $23.95
Upside: +87.89%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $100.78
Upside: -26.57%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.70
Upside: +103.70%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.80
Upside: +108.33%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.59
Upside: +178.55%
Jan 5, 2021
Upgrades: Buy
Price Target: $45 → $50
Current: $133.14
Upside: -62.45%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $15.00
Upside: -50.00%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $34.73
Upside: -48.17%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.16
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $35.02
Upside: -45.75%